FDA Makes It Official: Action On Human Growth Hormone Will Wait

Sandoz presents FDA's deferral of a decision on Omnitrope application as a tentative approval. The agency has completed its review of the recombinant human growth hormone product and did not identify any deficiencies, Sandoz says.